[ad_1] Merck’s multiple sclerosis drug evobrutinib didn’t meet a key goal in late-stage trials. The German pharmaceutical company’s phase 3 clinical trials for the drug did not achieve their primary…
Tag: medications
Roche Strikes Deal to Buy Drug Developer Carmot Therapeutics for $2.7 Bln
[ad_1] Roche aims to buy Carmot Therapeutics, a California-based pharmaceutical firm developing drugs to treat obesity and diabetes. The Swiss pharmaceutical company said it has entered an agreement to acquire…
Wegovy-Maker Novo Nordisk to Spend More Than $2 Billion Boosting Production in France
[ad_1] Pharmaceutical giant Novo Nordisk said it will invest more than 16 billion Danish kroner ($2.34 billion) in its French production site as it seeks to meet rising demand for…
Opinion | Is AI a Painkiller or a Vitamin?
[ad_1] Some companies will use it to reduce expenses, others to create new markets. [ad_2] Source link
GSK PLC Raises Guidance After RSV Vaccine Lifts Earnings
[ad_1] Updated Nov. 1, 2023 4:08 am ET GSK PLC raised its guidance after third-quarter net profit rose mainly due to the U.S. launch of its Arexvy vaccine, although it…
‘Guided Missile Drugs’ Could Be Big Pharma’s Secret Weapon
[ad_1] Merck and Pfizer are the latest big pharma companies to invest in this booming area. [ad_2] Source link
Opinion | The Covid Vaccine Windfall Turns for Pfizer and Moderna
[ad_1] Updated Nov. 19, 2023 3:03 pm ET The U.S. was in a fit of Covid panic during Thanksgiving week two years ago. The Omicron variant had emerged like a…